NBP 内幕交易
NBP 的 SEC Form 4 内幕交易记录
总交易
51
买入
1
买入总额
$577K
卖出总额
$268K
| 信号 | 内幕人 | 职位 | 方向 | 股数 | 价格 | 金额 | 日期 | 信号原因 |
|---|---|---|---|---|---|---|---|---|
| ★★★★★(43) | CAO SEAN WUXIONG | Chief Business Development Officer and Director | 卖出 | 21,399 | $1.99 | $43K | 2026-05-14 | C-suite卖出, 董事卖出 |
| ★★★★★(35) | CAO SEAN WUXIONG | Chief Business Development Officer and Director Exhibit List: Ex. 24.1 - Power of Attorney | 卖出 | 9,304 | $1.99 | $19K | 2026-05-14 | C-suite卖出, 董事卖出 |
| ★★★★★(26) | CAO SEAN WUXIONG | Chief Bus. Development Officer | 卖出 | 107,978 | $0.74 | $80K | 2026-09-09 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(25) | HAGLER MARK ARNOLD | President and Chief Commercial Officer | 买入 | 230,000 | $2.51 | $577K | 2026-04-24 | 高管买入, 大额买入(>$500K) |
| ★★★★★(18) | DENNIS PHILLIP ANDREW | Chief Medical Officer | 卖出 | 8,209 | $0.71 | $6K | 2026-09-18 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(18) | DENNIS PHILLIP ANDREW | Chief Medical Officer | 卖出 | 3,569 | $1.62 | $6K | 2026-09-18 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(18) | CAO SEAN WUXIONG | Chief Bus. Development Officer | 卖出 | 46,947 | $1.69 | $79K | 2026-09-09 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(18) | XU CONG CLAIRE | EVP, Clinical Development | 卖出 | 3,282 | $0.79 | $3K | 2026-08-31 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(18) | XU CONG CLAIRE | SVP, Clinical Development | 卖出 | 4,485 | $0.89 | $4K | 2026-07-06 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(18) | DENNIS PHILLIP ANDREW | Chief Medical Officer | 卖出 | 8,494 | $0.66 | $6K | 2026-06-18 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(18) | XU CONG CLAIRE | SVP, Clinical Development | 卖出 | 3,494 | $3.94 | $14K | 2026-06-01 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(18) | DENNIS PHILLIP ANDREW | - | 卖出 | 3,638 | $2.79 | $10K | 2026-03-18 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(0) | WOO IAN YING | - | 卖出 | 5,770 | - | - | 2026-10-15 | |
| ★★★★★(0) | WOO IAN YING | - | 卖出 | 13,271 | $1.37 | $18K | 2026-10-15 | |
| ★★★★★(0) | DENNIS PHILLIP ANDREW | Chief Medical Officer | 卖出 | 23,695 | $1.38 | $33K | 2026-09-17 | |
| ★★★★★(0) | DENNIS PHILLIP ANDREW | Chief Medical Officer | 卖出 | 10,302 | - | - | 2026-09-17 | |
| ★★★★★(0) | CAO SEAN WUXIONG | Chief Bus. Development Officer | 卖出 | 104,236 | $1.59 | $166K | 2026-09-03 | |
| ★★★★★(0) | CAO SEAN WUXIONG | Chief Bus. Development Officer | 卖出 | 45,320 | - | - | 2026-09-03 | |
| ★★★★★(0) | CAO SEAN WUXIONG | Chief Bus. Development Officer | 卖出 | 102,233 | - | - | 2026-09-03 | |
| ★★★★★(0) | CAO SEAN WUXIONG | Chief Bus. Development Officer | 卖出 | 235,136 | $1.59 | $374K | 2026-09-03 | |
| ★★★★★(0) | XU CONG CLAIRE | EVP, Clinical Development | 卖出 | 9,382 | $1.80 | $17K | 2026-08-30 | |
| ★★★★★(0) | XU CONG CLAIRE | EVP, Clinical Development | 卖出 | 4,079 | - | - | 2026-08-30 | |
| ★★★★★(0) | LENZ ROBERT A. | - | 卖出 | 7,486 | - | - | 2026-08-22 | |
| ★★★★★(0) | LENZ ROBERT A. | - | 卖出 | 17,218 | $1.84 | $32K | 2026-08-22 | |
| ★★★★★(0) | LIN LIWEI LORRAINE | General Counsel | 卖出 | 254,780 | - | - | 2026-07-08 | |
| ★★★★★(0) | HAGLER MARK ARNOLD | Chief Commercial Officer | 卖出 | 949,050 | - | - | 2026-07-08 | |
| ★★★★★(0) | GUPTA SRISHTI | Chief Executive Officer | 卖出 | 3,000,000 | - | - | 2026-07-06 | |
| ★★★★★(0) | XU CONG CLAIRE | SVP, Clinical Development | 卖出 | 5,405 | - | - | 2026-07-04 | |
| ★★★★★(0) | XU CONG CLAIRE | SVP, Clinical Development | 卖出 | 12,432 | - | - | 2026-07-04 | |
| ★★★★★(0) | FU WEI | - | 卖出 | 725,140 | - | - | 2026-06-29 | |
| ★★★★★(0) | FU WEI | - | 卖出 | 1,087,720 | - | - | 2026-06-29 | |
| ★★★★★(0) | FU WEI | - | 卖出 | 1,010,100 | - | - | 2026-06-29 | |
| ★★★★★(0) | CAO SEAN WUXIONG | Chief Bus. Development Officer | 卖出 | 181,280 | - | - | 2026-06-22 | |
| ★★★★★(0) | CAO SEAN WUXIONG | Chief Bus. Development Officer | 卖出 | 181,290 | - | - | 2026-06-22 | |
| ★★★★★(0) | DENNIS PHILLIP ANDREW | Chief Medical Officer | 卖出 | 10,302 | - | - | 2026-06-17 | |
| ★★★★★(0) | DENNIS PHILLIP ANDREW | Chief Medical Officer | 卖出 | 23,695 | - | - | 2026-06-17 | |
| ★★★★★(0) | XU CONG CLAIRE | SVP, Clinical Development | 卖出 | 4,079 | - | - | 2026-05-30 | |
| ★★★★★(0) | XU CONG CLAIRE | SVP, Clinical Development | 卖出 | 9,382 | - | - | 2026-05-30 | |
| ★★★★★(0) | XU CONG CLAIRE | Senior Vice President, Clinical Development | 卖出 | 0 | - | - | 2026-03-18 | |
| ★★★★★(0) | YANG CONOR CHIA-HUNG | - | 卖出 | 0 | - | - | 2026-03-18 | |
| ★★★★★(0) | DENNIS PHILLIP ANDREW | Chief Medical Officer | 卖出 | 0 | - | - | 2026-03-18 | |
| ★★★★★(0) | WU JOANNA XUQIONG | Senior Vice President, Head of Operations, General Counsel (US) Exhibit List: Ex. 24.1 - Power of Attorney | 卖出 | 0 | - | - | 2026-03-18 | |
| ★★★★★(0) | AU CHUN KWOK ALAN | - | 卖出 | 0 | - | - | 2026-03-18 | |
| ★★★★★(0) | WOO IAN YING | - | 卖出 | 0 | - | - | 2026-03-18 | |
| ★★★★★(0) | CAO SEAN WUXIONG | Chief Business Development Officer and Director Exhibit List: Ex. 24.1 - Power of Attorney | 卖出 | 0 | - | - | 2026-03-18 | |
| ★★★★★(0) | LEI MING KYLER | Chief Financial Officer | 卖出 | 0 | - | - | 2026-03-18 | |
| ★★★★★(0) | ZHANG XIAOFAN NEO | Chief Investment Officer | 卖出 | 0 | - | - | 2026-03-18 | |
| ★★★★★(0) | CUNNINGHAM EMMETT | - | 卖出 | 0 | - | - | 2026-03-18 | |
| ★★★★★(0) | FU XI-YONG | Chief Executive Officer and Director Exhibit List: Ex. 24.1 - Power of Attorney | 卖出 | 0 | - | - | 2026-03-18 | |
| ★★★★★(0) | FU WEI | - | 卖出 | 0 | - | - | 2026-03-18 | |
| ★★★★★(0) | LENZ ROBERT A. | - | 卖出 | 0 | - | - | 2026-03-18 |